Pterygium: UV, Prevention, and Why Wraparound Frames Matter

Pterygium is a benign fibrovascular growth that develops on the conjunctiva and spreads across the corneal surface, potentially encroaching on the visual axis and causing visual distortion, astigmatism, and vision impairment. It has the strongest documented dose-response relationship with UV exposure of any common ocular condition — more prevalent in high-UV regions, more common in outdoor workers, and concentrated on the side of the eye that receives the most UV at typical sun angles. Pterygium is surgically treatable but has a significant recurrence rate. Prevention through UV400 wraparound protection is more effective than surgical management. For the complete UV eye disease context, see the complete guide to UV and eye disease.

1. What Pterygium Is

Anatomy and Appearance

Pterygium (pronounced teh-RIJ-ee-um; plural pterygia) is a wedge-shaped or triangular growth of vascularized conjunctival tissue — fibrovascular tissue with blood vessels and inflammatory cells — that originates at the limbus (the border between the conjunctiva and the clear cornea) and extends onto the corneal surface. It is most commonly found on the nasal side of the eye (between the nose and the cornea) — the side that receives the most UV at typical outdoor sun angles — but can develop on the temporal side and, less commonly, bilaterally.

The surface appearance is distinctive: a fleshy, pink-white triangular or tongue-shaped lesion with visible blood vessels crossing from the white conjunctiva onto the clear corneal surface. In early stages, pterygium is confined to the peripheral cornea and may cause no visual symptoms. As it advances toward the central cornea and visual axis, it produces astigmatism (irregular corneal curvature from the tissue pulling the corneal surface), visual distortion, and eventually significant vision impairment when it crosses the visual axis.

Pinguecula: The Precursor

Pinguecula is the earlier, pre-corneal stage of the same UV-driven process — a yellowish-white deposit of UV-damaged conjunctival tissue that develops at the limbus without extending onto the cornea. Pinguecula does not impair vision but causes redness, irritation, and cosmetic concern. It is considered a risk factor for pterygium progression — many pterygia develop from existing pinguecula that advance onto the cornea over years. UV protection is the appropriate management for pinguecula to prevent progression to pterygium.

2. Why UV Causes Pterygium: The Mechanism

UV-Driven Cellular Changes at the Limbus

The limbus — the transition zone between the conjunctiva and cornea — is the anatomical site where pterygium originates. The limbus contains a population of limbal stem cells that normally maintain the corneal epithelium. UV exposure at the limbus triggers abnormal behavior in these and adjacent conjunctival cells through several mechanisms:

• UV-induced p53 mutation: UV-B causes specific mutations in the p53 tumor suppressor gene in limbal and conjunctival cells. p53 normally suppresses abnormal cell proliferation; p53 mutations allow cells to proliferate beyond normal boundaries. p53 mutations have been identified in pterygium tissue at rates consistent with UV-driven mutagenesis — providing molecular evidence for UV as the causative agent.
• Growth factor upregulation: UV exposure upregulates vascular endothelial growth factor (VEGF) and other growth factors in conjunctival cells, promoting the vascular proliferation that characterizes pterygium's fibrovascular tissue structure.
• Matrix metalloproteinase activation: UV activates enzymes that degrade the extracellular matrix at the corneoscleral junction, allowing conjunctival tissue to invade the normally protected corneal surface.
• Inflammatory pathway activation: UV triggers inflammatory signaling in conjunctival cells, promoting the fibroblast proliferation and fibrovascular tissue formation that compose pterygium's structural elements.

Why the Nasal Side: The UV Geometry

The predominant nasal location of pterygium is explained by the UV geometry of the eye in outdoor environments. When the sun is at a typical outdoor angle — from the side or slightly above — light enters the eye from the temporal side (the side toward the ear) and focuses, after passing through the cornea, onto the nasal limbus through a concentrating optical effect. The nasal limbus receives a concentrated UV dose from temporal sun exposure that is significantly higher than the limbal UV dose from other directions. This nasal UV concentration explains the nasal predominance of pterygium and is the mechanism behind the recommendation for wraparound sunglass designs that block temporal UV entry — the UV that focuses to the nasal limbus comes from the temporal direction, and blocking it at the temporal frame prevents the nasal limbal UV concentration.

3. Epidemiology: The Strongest UV-Dose Response of Any Eye Condition

Geographic Distribution

Pterygium prevalence follows UV geography more closely than any other common ocular condition. The "pterygium belt" — the geographic zone within approximately 37 degrees latitude of the equator — has significantly higher pterygium prevalence than higher-latitude populations at equivalent demographic characteristics. Australia has among the highest documented pterygium rates globally, consistent with its high UV environment and outdoor cultural exposure patterns. Within the United States, pterygium is more common in the Sun Belt states, in Hawaii, and in outdoor occupational groups across all geographic regions.

Occupational Exposure

Outdoor occupational groups — fishermen, farmers, construction workers, landscapers, outdoor athletes — have significantly higher pterygium rates than indoor workers in the same geographic regions. This occupational dose-response relationship provides strong evidence for UV (the primary distinguishing variable between occupational groups) as the causal factor rather than genetic or lifestyle variables shared within geographic populations.

UV Index and Prevalence

Population studies find near-linear dose-response relationships between average ambient UV index and pterygium prevalence — populations in UV index 6–8 environments have higher prevalence than UV index 3–5 populations, which have higher prevalence than UV index 1–2 populations. This dose-response linearity is stronger for pterygium than for cataracts or AMD, reflecting pterygium's more direct UV causation relative to the multifactorial disease processes of cataract and AMD.

4. Risk Factors

Risk Factor	Direction of Effect	Modifiable?
UV exposure (lifetime cumulative)	Strong positive — highest risk factor	Yes — UV400 protection
Geographic latitude (proximity to equator)	Strong positive — higher UV at lower latitude	Partially — relocation
Outdoor occupation	Strong positive — occupational UV dose	Partially — eye protection at work
Wind and dust exposure	Moderate positive — co-factor with UV	Yes — wraparound frames reduce wind exposure
Male sex	Moderate positive — higher occupational and recreational UV	No (behavioral exposure is modifiable)
Age (30–50s peak incidence)	Positive — reflects cumulative UV dose	No
Light iris color	Mild positive — less melanin UV filtration	No
Dry eye	Mild positive — ocular surface inflammation	Yes — artificial tears, treatment

5. Symptoms and Progression

Early Pterygium

Early pterygium confined to the peripheral cornea may produce no visual symptoms. Common complaints in early stages include: chronic redness of the nasal conjunctiva, mild irritation or foreign body sensation, cosmetic concern about the visible growth, and occasional dryness or tearing. Patients often notice the lesion when looking in a mirror or when others comment on persistent eye redness.

Progressive Pterygium

As pterygium advances toward the central cornea, the fibrovascular tissue pulls on the corneal surface, distorting its curvature. This produces:

• Astigmatism: irregular corneal curvature from the pterygium's mechanical traction on the corneal surface, causing distorted or blurred vision that worsens as the pterygium advances.
• Diplopia: double vision in some cases, from restricted eye movement if the pterygium involves the medial rectus muscle insertion area.
• Visual axis encroachment: when pterygium crosses the visual axis (the line of sight through the pupil), it directly blocks vision through the lens — a stage requiring surgical intervention.

Progression Rate

Pterygium progression varies considerably between individuals. Some pterygia are stationary for years; others advance steadily. Active pterygium — characterized by high vascularity, inflammation, and advancing edge — progresses more rapidly than quiescent lesions. Continued UV exposure accelerates progression; UV protection may slow or arrest progression in early-stage pterygium.

6. Treatment and the Recurrence Problem

Surgical Excision

Surgical pterygium excision is the only treatment that removes established pterygium. The standard modern technique — conjunctival autograft transplantation — involves excising the pterygium body and transplanting a graft of the patient's own conjunctival tissue from another part of the eye to the excision site. Conjunctival autograft has significantly lower recurrence rates than earlier bare sclera excision techniques.

Recurrence: The Major Limitation of Surgery

Pterygium recurrence following surgical excision is the major limitation of surgical management — recurrent pterygia are often more aggressive and vascularized than the primary lesion, and repeat surgery carries increasing technical difficulty and complication risk. Recurrence rates vary by technique and adjunctive treatment:

• Bare sclera excision alone: 30–80% recurrence rate (largely abandoned for primary pterygium)
• Conjunctival autograft: 5–15% recurrence rate — the current standard
• Autograft plus mitomycin-C (antimetabolite): lower recurrence rates but mitomycin-C carries scleral melting risk

Even with optimal surgical technique, pterygium recurrence remains a significant clinical problem — which is why prevention through UV protection, and UV protection following surgery to reduce recurrence risk, is the appropriate long-term management strategy.

7. Why Wraparound Frames Are Specifically Recommended for Pterygium Prevention

The Temporal UV Pathway to the Nasal Limbus

As established in the UV geometry section, the nasal limbus — where pterygium most commonly originates — receives concentrated UV from temporal sun exposure. UV entering the eye from the temporal side (between the frame and the face at the temple) focuses on the nasal limbus after passing through the cornea. Standard flat-lens sunglass frames that fit close to the face but have a gap at the temporal edge allow this temporal UV to enter and reach the nasal limbal region.

Wraparound frame designs that extend the lens curve around the temporal area of the face close this gap — blocking the temporal UV before it enters the eye. Studies of sunglass geometry and ocular UV exposure consistently find that wraparound designs reduce temporal UV entry by 90%+ compared to flat-lens designs, even when both provide UV400 lens protection. For pterygium prevention specifically — where the nasal limbal UV dose from temporal UV entry is the mechanistically relevant pathway — wraparound geometry provides meaningfully superior protection compared to flat-lens designs with the same UV400 specification.

Wind and Dust Reduction

Wind and dust exposure is a pterygium co-factor — it produces chronic ocular surface irritation and inflammation that may potentiate the UV-driven cellular changes at the limbus. Wraparound designs that reduce the airflow through the frame around the eye also reduce wind-driven dust and particulate exposure to the conjunctival surface. For outdoor workers and athletes in dusty or windy environments, the wind-reduction benefit of wraparound designs is an additional pterygium-relevant protective mechanism beyond UV blocking alone.

8. Post-Surgical UV Protection

UV Protection After Pterygium Surgery

UV protection following pterygium excision is as important as pre-surgical prevention — continued UV exposure is the primary driver of pterygium recurrence. Patients who undergo pterygium surgery and resume unprotected outdoor UV exposure are at elevated recurrence risk compared to those who maintain consistent UV400 protection post-operatively. Post-surgical UV protection recommendations typically include UV400 wraparound sunglasses for all outdoor activity, avoidance of peak UV hours during the healing period, and permanent UV protection habits thereafter.

The recommendation of wraparound designs is particularly important post-surgically — the conjunctival autograft and healing limbus are the most UV-sensitive tissues in the immediate post-operative period, and the temporal UV pathway to the nasal limbus that drove the original pterygium remains present. UV400 wraparound protection addresses both the lens and frame geometry requirements for post-surgical pterygium prevention.

Frequently Asked Questions

What does pterygium look like?

A fleshy, pink-white triangular or wedge-shaped growth with visible blood vessels extending from the white part of the eye (conjunctiva) onto the clear corneal surface, most commonly on the nasal side (between the nose and the colored part of the eye). It may appear as a persistent reddish area with a slightly raised, textured surface. Early pterygium is often first noticed in a mirror or pointed out by others commenting on persistent eye redness.

Is pterygium dangerous?

Pterygium is benign — it is not a cancer and does not metastasize. However, advanced pterygium causes significant clinical problems: astigmatism and visual distortion as it advances toward the corneal center, and vision impairment when it crosses the visual axis. The surgical management required for advanced pterygium carries operative risks and significant recurrence rates. Early-stage pterygium with UV protection may remain stable for years; untreated pterygium with continued UV exposure typically progresses.

Can pterygium go away on its own?

No — established pterygium does not spontaneously regress. It is either stable (not currently advancing) or progressive (advancing toward the visual axis). UV protection may slow or arrest progression in early-stage pterygium, but does not eliminate existing pterygium tissue. Surgical excision is the only treatment that removes pterygium once established; UV protection is the primary prevention and post-surgical recurrence prevention strategy.

Do I need wraparound sunglasses specifically for pterygium prevention?

For pterygium prevention specifically, wraparound designs provide meaningfully superior protection to flat-lens designs because of the temporal UV pathway to the nasal limbus — the UV that concentrates on the most common pterygium site enters from the temporal direction, where flat-lens frames leave a gap. UV400 lens protection alone does not address this temporal UV pathway. Wraparound designs that extend around the temporal face close the gap. For general UV protection, UV400 flat-lens designs are adequate; for pterygium-specific prevention in high-UV environments or post-surgically, wraparound geometry adds protective value.

Who is most at risk for pterygium?

Outdoor workers (construction, agriculture, fishing, landscaping) in high-UV geographic regions (within 37 degrees of the equator; Sun Belt states; high altitude); people with high lifetime recreational UV accumulation (surfers, outdoor athletes, hikers); individuals who have had previous pterygium (highest recurrence risk); and people with light-colored irides in high-UV environments. The primary risk factor is cumulative outdoor UV dose — anything that increases that dose increases pterygium risk.

Can pterygium affect both eyes?

Yes — bilateral pterygium occurs in a significant minority of cases, though unilateral presentation is more common. Bilateral pterygium typically presents asymmetrically — one eye more advanced than the other — reflecting asymmetries in UV exposure geometry from habitual outdoor behavior (the driver's left eye receives more UV from the driver's window; the side of the face most often toward the sun in habitual outdoor postures receives more limbal UV).

The Bottom Line

Pterygium has the strongest documented UV dose-response relationship of any common ocular condition — geography, occupation, and cumulative UV exposure all predict pterygium prevalence with a linearity that exceeds other UV eye diseases. Its treatment (surgical excision) is effective but limited by significant recurrence rates. Prevention through UV400 wraparound eye protection — blocking both the direct UV through the lens and the temporal UV pathway to the nasal limbus — is the most effective pterygium management strategy available. For anyone in a high-UV environment, with a history of significant outdoor exposure, or post-pterygium surgery, UV400 wraparound protection is the evidence-based recommendation. navieyewear.com/collections/polarized — Buy 1, Get 3 Free for $119.

---

Related Reading

• UV and Eye Disease: The Complete Guide | Navi Eyewear
• UV and Cataracts: Prevention, Risk Factors, and Research | Navi Eyewear
• Macular Degeneration and UV | Navi Eyewear
• Photokeratitis and Snow Blindness | Navi Eyewear
• Sunglass Frame Technology and Materials | Navi Eyewear
• Sunglasses for Outdoor Workers | Navi Eyewear
• Sunglasses for Cruise and Open Water | Navi Eyewear
• Shop Polarized UV400 Sunglasses | Navi Eyewear

---

Sources & Citations

[1] Coroneo MT. "Pterygium as an indicator of ultraviolet-B radiation damage: time to assess its role as a proxy measure of lifetime ocular UV exposure." Eye, 1993. View source →

[2] Moran DJ and Hollows FC. "Pterygium and ultraviolet radiation: a positive correlation." British Journal of Ophthalmology, 1984. View source →

[3] Threlfall TJ and English DR. "Sun exposure and pterygium of the eye: a dose-response curve." American Journal of Ophthalmology, 1999. View source →

[4] Dushku N and Reid TW. "Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells." Current Eye Research, 1994. View source →

[5] Sliney DH. "Ocular exposure to environmental light and ultraviolet." Journal of AAPOS, 2014. View source →

[6] WHO. "Global solar UV index: a practical guide." World Health Organization, 2002. View source →

[7] Rosenthal FS, et al. "The effect of sunglasses on ocular exposure to ultraviolet radiation." American Journal of Public Health, 1988. View source →